Abvc Biopharma Inc (ABVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
06-2011 | 03-2011 | 12-2010 | 09-2010 | 06-2010 | |
Sales | 0 | 1 | 2 | 1 | 3 |
Gross Profit | 0 | 1 | 2 | 1 | 3 |
Operating Expenses | 770 | 330 | 370 | 0 | 0 |
Operating Income | -770 | -329 | -368 | 1 | 3 |
Interest Expense | 40 | 60 | 50 | 0 | 0 |
Other Income | 0 | 869 | -2 | 0 | 0 |
Pre-tax Income | -810 | 480 | -420 | 1 | 3 |
Net Income Continuous | -815 | 483 | -424 | -380 | -209 |
Net Income | $-815 | $483 | $-424 | $-380 | $-209 |
EPS Basic Total Ops | -31,493.43 | -20,041.27 | -20,041.27 | -20,041.27 | -2,863.04 |
EPS Basic Continuous Ops | -31,493.43 | -20,041.27 | -20,041.27 | -20,041.27 | -2,090.00 |
EPS Diluted Total Ops | -31,493.43 | -20,041.27 | -20,041.27 | -20,041.27 | -2,863.04 |
EPS Diluted Continuous Ops | -31,493.43 | -20,041.27 | -20,041.27 | -20,041.27 | -2,090.00 |
EBITDA(a) | $-760 | $-319 | $-398 | $1 | $3 |